Abstract
A mathematical model for the transmission dynamics of Coronavirus diseases (COVID-19) is proposed by incorporating self-protection behavior changes in the population. The disease-free equilibrium point is computed and its stability analysis is studied. The basic reproduction number(R0) of the model is computed and the disease-free equilibrium point is locally and globally stable for R0 < 1 and unstable for R0 > 1. Based on the available data the unknown model parameters are estimated using a combination of least square and Bayesian estimation methods for different countries. Using forward sensitivity index the model parameters is carried out to determine and identify the key factors for the spread of disease dynamics. From country to country the sensitive parameters for the spread of the virus varies. It is found out that the reproduction number depends mostly on the infection rates, the threshold value of the force of infection for a population, the recovery rates, and the virus decay rate in the environment. It is also demonstrated that control of the effective transmission rate (recommended human behavioral change towards self-protective measures) is essential to stop the spreading of the virus. Numerical simulations also show that the virus’s transmission dynamics depend mostly on those sensitive parameters.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
It is a research on Mathematical Epidemiology
Funding Statement
There is no funding for this work
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
There are no IRB/oversight body
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The data in this study are available online on worldometer and WHO websites.
https://www.worldometers.info/coronavirus and https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports
